Press Releases Archives - Page 2 of 4 - Sun Pharmaceutical Industries Ltd.

Sun Pharma receives approval to manufacture and market generic semaglutide in South Africa

Sun Pharma receives approval to manufacture and market generic semaglutide in South Africa

by ananthi | Jul 15, 2026 | Press Releases

Read More

Sun Pharma’s #SecondBirthDate Returns with Shreyas Iyer

Sun Pharma’s #SecondBirthDate Returns with Shreyas Iyer

by ananthi | Jun 29, 2026 | Press Releases

Read More

SPIL Q4FY26 Financial Results

SPIL Q4FY26 Financial Results

by ananthi | May 22, 2026 | Press Releases

Read More

Press Release Sun Pharma reports Q4 & full year results for FY26

Press Release Sun Pharma reports Q4 & full year results for FY26

by ananthi | May 22, 2026 | Press Releases

Read More

SPIL Q4FY26 Financial Results

Sun Pharma signs Definitive Agreement to Acquire Organon

by ananthi | Apr 27, 2026 | Press Releases

Read More

Sun Pharma receives approval to manufacture and market generic semaglutide in South Africa

Sun Pharma launches its semaglutide injection under the brand names, Noveltreat and Sematrinity in India

by ananthi | Mar 21, 2026 | Press Releases

Read More

« Older Entries

Next Entries »

Top